Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

CONNECT BIOPHARMA HOLDINGS LIMITED

(CNTB)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Connect Biopharma : Names General Counsel & Chief Compliance Officer

08/23/2021 | 04:16pm EDT


ę MT Newswires 2021
All news about CONNECT BIOPHARMA HOLDINGS LIMITED
09/20CONNECT BIOPHARMA HOLDINGS LIMITED(N : CNTB) added to S&P Global BMI Index
CI
09/15Certain Ordinary Shares of Connect Biopharma Holdings Limited are subject to a Lock-Up ..
CI
09/08CONNECT BIOPHARMA : Doses First Patient in Phase 2 Trial of CBP-201 to Treat Chronic Rhino..
MT
09/08CONNECT BIOPHARMA : Announces First Subject Dosed in Phase 2 Trial Evaluating CBP-201 in A..
PU
09/08Connect Biopharma Holdings Limited Announces First Subject Dosed in Phase 2 Trial Evalu..
CI
09/08CONNECT BIOPHARMA : Announces First Subject Dosed in Phase 2 Trial Evaluating CBP-201 in A..
AQ
09/02CONNECT BIOPHARMA : Announces First Patient Dosed in China Pivotal Trial Evaluating CBP-20..
PU
09/02CONNECT BIOPHARMA : Starts Dosing in Chinese Trial of Atopic Dermatitis Treatment
MT
09/02CONNECT BIOPHARMA : Announces First Patient Dosed in China Pivotal Trial Evaluating CBP-20..
AQ
09/02Connect Biopharma Holdings Limited Announces First Patient Dosed in China Pivotal Trial..
CI
More news
Analyst Recommendations on CONNECT BIOPHARMA HOLDINGS LIMITED
More recommendations
Financials
Sales 2021 - - -
Net income 2021 -1 316 M -205 M -205 M
Net cash 2021 1 559 M 242 M 242 M
P/E ratio 2021 -4,49x
Yield 2021 -
Capitalization 5 858 M 910 M 910 M
EV / Sales 2021 -
EV / Sales 2022 -
Nbr of Employees 62
Free-Float 92,8%
Chart CONNECT BIOPHARMA HOLDINGS LIMITED
Duration : Period :
Connect Biopharma Holdings Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CONNECT BIOPHARMA HOLDINGS LIMITED
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 17,17 $
Average target price 29,25 $
Spread / Average Target 70,4%
EPS Revisions
Managers and Directors
Zheng Wei Chief Executive Officer & Director
Wu Bin Pan Chairman & President
Eric J. Hall Chief Financial Officer
Pauline Li VP & Head-Asia Clinical Development
Jiang Bian Chief Compliance Officer & General Counsel
Sector and Competitors
1st jan.Capi. (M$)
CONNECT BIOPHARMA HOLDINGS LIMITED0.00%910
GILEAD SCIENCES, INC.16.08%84 795
WUXI APPTEC CO., LTD.29.45%66 184
BIONTECH SE203.83%59 820
REGENERON PHARMACEUTICALS14.52%57 519
VERTEX PHARMACEUTICALS-23.09%47 156